BN GLOBAL FUND RESEARCH
Nippon India Pharma Fund - Growth
Nippon India Mutual Fund · Sectoral/ Thematic · Regular Plan · Growth
NAV PERFORMANCE
Growth over time
Month-end NAV history supplied for the selected scheme.
INVESTMENT ILLUSTRATION
SIP & lump-sum calculator
Illustration for Nippon India Pharma Fund - Growth uses the closest available historical return for the selected period. It is not a forecast or recommendation; actual returns will vary.
RETURN COMPARISON
Historical returns
Regular Plan · Growth returns as at 20-11-2026. Returns above one year are annualised. Shorter periods: 1 week 1.02%, 1 month 11.32%, 3 months 3.52%, 6 months 8.09% .
PORTFOLIO
What the fund holds
Nippon India Mutual Fund’s portfolio disclosure for Oct 2026 · 37 holdings · 99.6% in equity
Top 10 holdings
| Holding | Sector | % of fund |
|---|---|---|
| Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 11.55% |
| Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 6.73% |
| Cipla Limited | Pharmaceuticals & Biotechnology | 6.21% |
| Lupin Limited | Pharmaceuticals & Biotechnology | 6.16% |
| Dr. Reddy's Laboratories Limited | Pharmaceuticals & Biotechnology | 6.13% |
| Apollo Hospitals Enterprise Limited | Healthcare Services | 5.10% |
| Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 4.40% |
| Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | 4.04% |
| Ajanta Pharma Limited | Pharmaceuticals & Biotechnology | 3.53% |
| Max Healthcare Institute Limited | Healthcare Services | 3.31% |
Sectors
- Pharmaceuticals & Biotechnology75.01%
- Healthcare Services21.82%
- Retailing2.26%
- Healthcare Equipment & Supplies0.53%
RISK
SEBI risk-o-meter
Rated Very High, level 6 of 6, by Nippon India Mutual Fund (as of 31 Oct 2026).
The risk-o-meter is the fund house’s own rating under SEBI rules, from Low to Very High. It can change from month to month.
Figures as of 20 Nov 2026 (NAV history to 15 Oct 2026). If an update is delayed, the last figures received are shown until new data arrives.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance does not guarantee future returns. Scheme information is date-stamped; availability and NRI eligibility must be confirmed before investing. BN Global Private Office is an AMFI-registered mutual fund distributor (ARN-OD122699).